Ronald A. Pepin

Corporate Officer/Principal at CELLDEX THERAPEUTICS, INC.

Net worth: - $ as of 2024-04-29

68 year

Health Technology

Consumer Services

Commercial Services

Ronald A. Pepin active positions

Companies	Position	Start	End
CELLDEX THERAPEUTICS, INC.	Corporate Officer/Principal	2011-07-07	-
Antyra, Inc. Antyra, Inc. Pharmaceuticals: MajorHealth Technology Antyra, Inc. develops cancer therapeutics. Its products include lead programs, a program to generate and develop disease-specific therapeutics; oncology leads, such as IGF-1R Antagonist, which represent a clinical strategy for the treatment of pancreatic and other cancers; and ANT-G12, a technology that isolates cytotoxic peptimetics that bind to cell surface targets expressed in a disease-specific context. The company was founded by by John K. A. Prendergast and Arthur J. Blume in 1996 and is headquartered in Edison, NJ.	Director/Board Member	-	-

Companies	Position	Start	End
Medarex, Inc. Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey.	Corporate Officer/Principal	2000-07-31	2008-12-31
BRISTOL-MYERS SQUIBB COMPANY	Chief Tech/Sci/R&D Officer	1990-02-28	2000-06-30
Shire Pharmaceuticals, Inc. Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA	Corporate Officer/Principal	-	-

Tufts University	Undergraduate Degree
Georgetown University	Doctorate Degree

International

United States

Operational

Corporate Officer/Principal	3
Chief Tech/Sci/R&D Officer	1
Undergraduate Degree	1

Sectoral

Positions held

Active

Inactive

Listed companies

Private companies

Listed companies	2
BRISTOL-MYERS SQUIBB COMPANY	Health Technology
CELLDEX THERAPEUTICS, INC.	Health Services

Private companies	3
Medarex, Inc. Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey.	Commercial Services
Antyra, Inc. Antyra, Inc. Pharmaceuticals: MajorHealth Technology Antyra, Inc. develops cancer therapeutics. Its products include lead programs, a program to generate and develop disease-specific therapeutics; oncology leads, such as IGF-1R Antagonist, which represent a clinical strategy for the treatment of pancreatic and other cancers; and ANT-G12, a technology that isolates cytotoxic peptimetics that bind to cell surface targets expressed in a disease-specific context. The company was founded by by John K. A. Prendergast and Arthur J. Blume in 1996 and is headquartered in Edison, NJ.	Health Technology
Shire Pharmaceuticals, Inc. Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA	Health Technology